{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:13:01Z","timestamp":1783624381477,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the clinical value of cytokeratin 19 fragment (CYFRA21-1) and its correlation with Krebs von den Lungen-6 (KL-6) in stratifying the severity of rheumatoid arthritis-associated interstitial lung disease (RA-ILD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were retrospectively collected from 178 patients with rheumatoid arthritis (RA) admitted to our hospital between November 2024 and September 2025. The classification of patients into subgroups was based on chest high-resolution computed tomography (HRCT) findings, with 82 without interstitial lung disease (ILD), 53 with mild ILD, and 43 with advanced ILD. Serum KL-6 levels were measured using a latex agglutination assay, and the levels of tumor markers were determined by chemiluminescent immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum CYFRA21-1 levels were significantly higher in both the RA-mild ILD and RA-advanced ILD groups compared with the RA-no ILD group (2.10 ng\/mL vs. 1.90 ng\/mL,\n                      <jats:italic>q<\/jats:italic>\n                      = 0.024; 3.70 ng\/mL vs. 1.90 ng\/mL,\n                      <jats:italic>q<\/jats:italic>\n                      &amp;lt; 0.001). Multivariate analysis demonstrated that CYFRA21-1 was an independent risk factor for RA-mild ILD [odds ratio (OR) = 1.711, 95% confidence interval (CI) = 1.160\u20132.523,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.007] and RA-advanced ILD (OR = 4.819, 95% CI = 2.942\u20137.892,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). KL-6 and CYFRA21-1 showed strong negative correlations with predicted forced vital capacity (FVC% pred), with correlation coefficients decreasing to \u22120.877 and \u22120.763 in the advanced ILD group, their positive correlation progressively increased with disease severity (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.453\u20130.649). Furthermore, receiver operating characteristic (ROC) curve analysis indicated that CYFRA21-1 had diagnostic value for both RA-ILD (mild + advanced) and RA-advanced ILD. The area under the ROC curve (AUC) of CYFRA21-1 in RA-ILD was 0.73 (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001; sensitivity = 61.86%; specificity = 78.05%), while that in RA-advanced ILD was 0.88 (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001; sensitivity = 84.09%; specificity = 78.05%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CYFRA21-1 exhibited graded expression and a positive correlation with KL-6, serving as a valuable serum biomarker for risk stratification and severity assessment in RA-ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1763928","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:24:38Z","timestamp":1775107478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Gradient elevation of serum CYFRA21-1 and its synergy with KL-6 for risk stratification in rheumatoid arthritis-associated interstitial lung disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingjing","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasa","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis.","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1529-0131(199904)42:33.0.CO;2-Z","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality.","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality.","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","article-title":"Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population.","volume":"8","author":"Zheng","year":"2021","journal-title":"Rheumatol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5606\/ArchRheumatol.2018.6691","article-title":"Tumor-associated antigens in rheumatoid arthritis interstitial lung disease or malignancy?","volume":"33","author":"Sargin","year":"2018","journal-title":"Arch Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e24726","DOI":"10.1002\/jcla.24726","article-title":"Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease.","volume":"36","author":"Li","year":"2022","journal-title":"J Clin Lab Anal."},{"key":"B11","doi-asserted-by":"publisher","first-page":"C483","DOI":"10.1152\/ajpcell.00239.2023","article-title":"Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis.","volume":"325","author":"Parimon","year":"2023","journal-title":"Am J Physiol Cell Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis.","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease.","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3899\/jrheum.2024-0713","article-title":"Serum biomarkers of pulmonary damage and risk for progression of rheumatoid arthritis-associated interstitial lung disease.","volume":"52","author":"Chang","year":"2025","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/jpm13111607","article-title":"Exploring the role of biomarkers associated with alveolar damage and dysfunction in idiopathic pulmonary fibrosis-a systematic review.","volume":"13","author":"Zamfir","year":"2023","journal-title":"J Pers Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.acra.2009.07.016","article-title":"Identification of early interstitial lung disease in smokers from the COPDGene study.","volume":"17","author":"Washko","year":"2010","journal-title":"Acad Radiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease.","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities.","volume":"364","author":"Washko","year":"2011","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1148\/radiol.2463062200","article-title":"Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality.","volume":"246","author":"Best","year":"2008","journal-title":"Radiology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S2213-2600(15)00096-X","article-title":"CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society.","volume":"3","author":"Hansell","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B24","first-page":"151","article-title":"Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis.","volume":"46","author":"Kohno","year":"1999","journal-title":"J Med Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.26355\/eurrev_202306_32783","article-title":"Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals.","volume":"27","author":"Balci","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B26","first-page":"587","article-title":"Tumour markers in rheumatoid arthritis-associated interstitial lung disease.","volume":"34","author":"Wang","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12890-025-03558-4","article-title":"Serum carbohydrate antigen 153 as a predictor of interstitial lung disease associated with rheumatoid arthritis is positively correlated with serum Krebs von den Lungen-6.","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Pulm Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0229997","DOI":"10.1371\/journal.pone.0229997","article-title":"Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/rheumatology\/key420","article-title":"Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.","volume":"58","author":"Takanashi","year":"2019","journal-title":"Rheumatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/IJGM.S310917","article-title":"Correlation between serum tumor marker levels and connective tissue disease-related interstitial lung disease.","volume":"14","author":"Bao","year":"2021","journal-title":"Int J Gen Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1261483","DOI":"10.3389\/fimmu.2023.1261483","article-title":"Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death.","volume":"14","author":"Carignon","year":"2023","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/01902148.2015.1073407","article-title":"CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.","volume":"41","author":"Vercauteren","year":"2015","journal-title":"Exp Lung Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1164\/rccm.202204-0708LE","article-title":"The need for a CYFRA 21-1 cutoff value to predict clinical progression of IPF in clinical practice.","volume":"206","author":"Fujimoto","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/cs0940531","article-title":"CYFRA 21-1, a cytokeratin subunit 19 fragment, in bronchoalveolar lavage fluid from patients with interstitial lung disease.","volume":"94","author":"Kanazawa","year":"1998","journal-title":"Clin Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1164\/rccm.202107-1769OC","article-title":"CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.","volume":"205","author":"Molyneaux","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12890-025-04010-3","article-title":"Serum CYFRA21-1 as a novel biomarker for predicting progressive pulmonary fibrosis in non-IPF interstitial lung disease, a cohort study.","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Pulm Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1034\/j.1399-3003.1999.14c15.x","article-title":"Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia.","volume":"14","author":"Dobashi","year":"1999","journal-title":"Eur Respir J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1564176","DOI":"10.3389\/fmolb.2025.1564176","article-title":"Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis.","volume":"12","author":"Zheng","year":"2025","journal-title":"Front Mol Biosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","article-title":"Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation.","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1111\/jcmm.17475","article-title":"IL-23 plays a significant role in the augmentation of particulate matter-mediated allergic airway inflammation.","volume":"26","author":"Lee","year":"2022","journal-title":"J Cell Mol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1021\/acsnano.3c10547","article-title":"Targeting senescent alveolar epithelial cells using engineered mesenchymal stem cell-derived extracellular vesicles to treat pulmonary fibrosis.","volume":"18","author":"Long","year":"2024","journal-title":"ACS Nano."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.bbrc.2005.10.144","article-title":"KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.","volume":"338","author":"Ohshimo","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1165\/ajrcmb.17.4.2253","article-title":"KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts.","volume":"17","author":"Hirasawa","year":"1997","journal-title":"Am J Respir Cell Mol Biol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1763928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:24:40Z","timestamp":1775107480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1763928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":43,"alternative-id":["10.3389\/fmed.2026.1763928"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1763928","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1763928"}}